Wall Street Zen Downgrades Lumexa Imaging (NASDAQ:LMRI) to Hold

Lumexa Imaging (NASDAQ:LMRI) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a report issued on Saturday, Wall Street Zen reports.

A number of other research analysts have also recently weighed in on the company. Barclays lifted their target price on Lumexa Imaging from $9.00 to $13.00 and gave the company an “overweight” rating in a report on Friday, August 28th. Weiss Ratings raised Lumexa Imaging from a “sell (e)” rating to a “sell (d)” rating in a research note on Thursday, June 25th. Finally, Deutsche Bank Aktiengesellschaft set a $16.00 target price on Lumexa Imaging in a report on Thursday, August 13th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Lumexa Imaging has an average rating of “Moderate Buy” and an average target price of $17.33.

Lumexa Imaging Stock Performance

Shares of LMRI stock opened at $11.49 on Friday. Lumexa Imaging has a one year low of $6.45 and a one year high of $19.45. The company has a debt-to-equity ratio of 1.40, a quick ratio of 1.44 and a current ratio of 1.44. The company has a 50 day moving average price of $11.53 and a 200 day moving average price of $10.67. The firm has a market capitalization of $1.10 billion and a price-to-earnings ratio of -23.45.

Lumexa Imaging (NASDAQ:LMRI) last posted its quarterly earnings results on Wednesday, August 12th. The company reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.17. The company had revenue of $264.16 million for the quarter. Lumexa Imaging has set its FY 2026 guidance at 0.710-0.770 EPS. Sell-side analysts anticipate that Lumexa Imaging will post 0.25 EPS for the current year.

Hedge Funds Weigh In On Lumexa Imaging

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Jupiter Topco LLC purchased a new stake in shares of Lumexa Imaging during the second quarter valued at approximately $24,269,000. Janus Henderson Group PLC grew its holdings in Lumexa Imaging by 5.4% during the 1st quarter. Janus Henderson Group PLC now owns 2,100,356 shares of the company’s stock valued at $18,063,000 after purchasing an additional 107,903 shares in the last quarter. T. Rowe Price Investment Management Inc. acquired a new stake in Lumexa Imaging during the 4th quarter valued at $37,139,000. Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in Lumexa Imaging during the 4th quarter worth $27,750,000. Finally, ArrowMark Colorado Holdings LLC acquired a new position in Lumexa Imaging in the 4th quarter worth $27,750,000.

About Lumexa Imaging

Lumexa Imaging, Inc (NASDAQ: LMRI) is an outpatient diagnostic imaging company that provides medical imaging services to patients and referring healthcare providers in the United States. Its services are designed to support the diagnosis, monitoring and management of a wide range of medical conditions.

The company’s imaging capabilities include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET/CT), ultrasound, mammography and X-ray services. Lumexa also provides related radiology and imaging-support services through its outpatient centers and other care-delivery arrangements.

Lumexa Imaging was formerly known as Akumin Inc and adopted the Lumexa Imaging name as part of its corporate rebranding.